H

Heron Therapeutics
D

HRTX

1.07500
USD
0.03
(2.38%)
مغلق
حجم التداول
32,279
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
163,502,030
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    E
    EXEL
    -0.600
    (-1.71%)
    34.450 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    المزيد
الأخبار

العنوان: Heron Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.